View of Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis

Return to Article Details Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis Download Download PDF